NextGen Jane
PrivateLast Round
Grant
May 12, 2025
Total Funding Raised
$20.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NextGen Jane is a biotechnology company that provides diagnostic tools designed to offer information and data on women's reproductive health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Government Contracts, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NextGen Jane Comparables
Compare NextGen Jane with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endometrics | 91% | |
| DotLab | 85% | |
| Nura Health | 83% |
NextGen Jane Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 12, 2025 | ||||
| Series B | Oct 2, 2023 | ||||
| Grant | Feb 22, 2022 | ||||
| Series A | Mar 29, 2019 | ||||
| Seed | Mar 1, 2016 | ||||
Accelerator | Dec 9, 2015 |
NextGen Jane Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series A, Series B, Seed |
| NIH RADx | Grant |
| Material Impact | Series B, Series A |
| Viking Global Investors | Series A |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 185% MoM, reaching 3.8K.
- Jan 5, 2026
Monthly visitors increased 167% MoM, reaching 6.8K.
NextGen Jane Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NextGen Jane's valuation, stock price, and market status.
Is NextGen Jane a public or private company?
NextGen Jane is a private company.
What is the current stock price of NextGen Jane?
NextGen Jane is a private company, so its shares have no public market price. Caplight tracks NextGen Jane's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NextGen Jane worth (valuation)?
Valuation information for NextGen Jane is not publicly available.
Can I buy NextGen Jane stock?
NextGen Jane shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NextGen Jane's last funding round?
NextGen Jane's most recent funding round was Grant on May 12, 2025.
Who are the main investors in NextGen Jane?
Key investors in NextGen Jane include Access Industries, Material Impact, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Illumina Accelerator.
Will NextGen Jane IPO soon?
No public IPO plans have been announced for NextGen Jane.
How can I track NextGen Jane secondary market activity?
Caplight tracks bids, offers, and trades in NextGen Jane's shares on secondary markets.